Content Links:
Program Overview
Target Audience
Commercial Support Acknowledgement
Educational Objectives
Course Directors and Program Faculty
Program Moderators
Dates/Cities
Schedule for all Programs
Sunshine Act
Accreditation Statement
Credit Designation Statement
Disclosure of Conflicts of Interest
Program Overview:
The treatment of people with HIV infection is rapidly and constantly progressing. With many antiretrovirals (ARVs) and ARV combinations available, clinicians caring for HIV-positive patients have increasingly complex choices regarding ARV therapy. While these medications provide important options for treating patients with HIV infection, they also present new challenges, because it is not always possible for clinicians to keep up with the flood of information available that they need to provide optimal, individualized care. This situation can contribute to increased morbidity and mortality in HIV-positive patients. To address this problem, the HIV in 2014 program provides a series of quarterly CME dinner programs in six major cities in the United States. The winter series will feature an update from the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2014) and the HIV Drug Therapy Glasgow Meeting (HIV 11).
The two-hour programs will feature one national level faculty and one program moderator who will present and discuss key topics in HIV patient care. These case-based programs will provide new clinical information that will help health care providers address knowledge gaps concerning the treatment of a wide range of patient types and treatment scenarios. The audience will receive the knowledge needed to address professional practice gaps, which should result in more individualized therapy, fewer long-term adverse effects, improved adherence, and reduced viral loads, and ultimately to a reduction in morbidity and mortality.
Back to Top
Target Audience:
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals actively involved in the treatment and management of patients with HIV-infection. It is tuition-free and there are no prerequisites.
Back to Top
Commercial Support Acknowledgement:
This activity is supported by an unrestricted educational grant by Gilead Sciences Medical Affairs.
Back to Top
Educational Objectives:
Upon completion of the activity, participants should be able to:
- Initiate current ARV drug options available for treatment-naïve patients with HIV based upon major guideline recommendations and current clinical research findings
- Describe preventive care and treatment for the important opportunistic infections and co-morbidities that may increase the risk for morbidity and mortality in HIV positive patients
- Describe the importance of individualizing the care of each HIV-positive patient in clinical practice
Back to Top
Course Directors and Program Faculty:
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts |
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania |
Back to Top
Program Moderators:
Roberto C. Arduino, MD
Professor of Medicine,
UT Director of Research,
Thomas Street Clinic
The University of Texas-Houston
Houston, Texas
|
Lisa Capaldini, MD
Assistant Clinical Professor of Medicine,
University of California San Francisco School of Medicine
San Francisco, California
|
Anthony Mills, MD
Medical Director, Southern California Men's Medical Group
Executive Director, Men's Health Foundation
Principle Investigator, Mills Clinical Group
Assistant Professor of Clinical Medicine, UCLA
Los Angeles, California
|
Renslow Sherer, MD
Professor of Medicine,
Section of Infectious Diseases
and Global Health
University of Chicago
Chicago, Illinois
|
Michael Sension, MD
Physician,
Comprehensive Care Center
Ft. Lauderdale, Florida
|
Antonio A. Urbina, MD
Associate Medical Director,
Center for Comprehensive Care
West Village Division
St. Luke's Roosevelt Hospital
New York, New York
|
Back to Top
Dates/Cities - Winter:
Tuesday, November 11, 2014
Los Angeles, CA |
Wednesday, November 12, 2014
Houston, TX |
Wednesday, November 12, 2014
Chicago, IL |
Thursday, November 13, 2014
New York, NY
|
Thursday, November 13, 2014
San Francisco, CA |
Wednesday, November 19, 2014
Miami, FL |
Back to Top
Schedule for all Programs:
6:00 - 6:30 PM Check-in/Walk-in Registration
6:30 - 8:30 PM Program and Q&A
Back to Top
Sunshine Act:
As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.
Back to Top
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Back to Top
Credit Designation Statement:
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Back to Top
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Back to Top
We look forward to bringing the highest-quality CME directly to you.
|